Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 372

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome

Open access
Pinney, Jennifer H., Whelan, Carol J., Petrie, Aviva, Dungu, Jason, Banypersad, Sanjay M., Sattianayagam, Prayman, Wechalekar, Ashutosh, Gibbs, Simon D. J., Venner, Christopher P., Wassef, Nancy, McCarthy, Carolyn A., Gilbertson, Janet A., Rowczenio, Dorota, Hawkins, Philip N., Gillmore, Julian D., Lachmann, Helen J.·2013·Journal of the American Heart Association

Abstract

Background: Cardiac amyloidosis is a fatal disease whose prognosis and treatment rely on identification of the amyloid type. In our aging population transthyretin amyloidosis ( ATTR wt) is common and must be differentiated from other amyloid types. We report the clinical presentation, natural history, and prognostic features of ATTR wt compared with cardiac‐isolated AL amyloidosis and calculate the probability of disease diagnosis of ATTR wt from baseline factors. Methods and Results: All patients with biopsy‐proven ATTR wt (102 cases) and isolated cardiac AL (36 cases) seen from 2002 to 2011 at the UK National Amyloidosis Center were included. Median survival from the onset of symptoms was 6.07 years in the ATTR wt group and 1.7 years in the AL group. Positive troponin, a pacemaker, and increasing New York Heart Association (NYHA) class were associated with worse survival in ATTR wt patients on univariate analysis. All patients with isolated cardiac AL and 24.1% of patients with ATTR wt had evidence of a plasma cell dyscrasia. Older age and lower N ‐terminal pro‐ B ‐type natriuretic peptide ( NT pro‐ BNP ) were factors significantly associated with ATTR wt. Patients aged 70 years and younger with an NT pro‐ BNP <183 pmol/L were more likely to have ATTR wt, as were patients older than 70 years with an NT pro‐ BNP <1420 pmol/L. Conclusions: Factors at baseline associated with a worse outcome in ATTR wt are positive troponin T, a pacemaker, and NYHA class IV symptoms. The age of the patient at diagnosis and NT pro‐ BNP level can aid in distinguishing ATTR wt from AL amyloidosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/jaha.113.000098

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 372

Metadata

Authors
Pinney, J. H., Whelan, C. J., Petrie, A., Dungu, J., Banypersad, S. M., Sattianayagam, P., Wechalekar, A., Gibbs, S. D. J., Venner, C. P., Wassef, N., McCarthy, C. A., Gilbertson, J. A., Rowczenio, D., Hawkins, P. N., Gillmore, J. D., & Lachmann, H. J.
Venue
Journal of the American Heart Association
Published
2013-03-12
Volume
2
Issue
2
Pages
e000098-e000098
ISSN
2047-9980 (ISSN-L)
OpenAlex
W2133199265
Cited by
372
References
27
FWCI
8.20
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome. https://app.cochat.ai/papers/10.1161/jaha.113.000098
The paper
Pinney, J. H., Whelan, C. J., Petrie, A., Dungu, J., Banypersad, S. M., Sattianayagam, P., Wechalekar, A., Gibbs, S. D. J., Venner, C. P., Wassef, N., McCarthy, C. A., Gilbertson, J. A., Rowczenio, D., Hawkins, P. N., Gillmore, J. D., & Lachmann, H. J. (2013). Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome. Journal of the American Heart Association. https://doi.org/10.1161/jaha.113.000098

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.